Search - tctmd.com

Displaying 721 - 740 of 2765

Sort: Relevancy | Date

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Opinion Editor's Corner

Glancing Back, Looking Forward: Lasting Lessons for Years to Come

Shelley Wood

December 27, 2021

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Yael L. Maxwell

December 14, 2021

News Daily News

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

Todd Neale

December 14, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

Todd Neale

December 09, 2021

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

L.A. McKeown

December 07, 2021

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

News Daily News

Penumbra’s JET 7 Recall: A Kick Start to Change?

Caitlin E. Cox

December 01, 2021

News Daily News

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

Michael O'Riordan

November 29, 2021

News Conference News AHA 2021

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Michael O'Riordan

November 22, 2021

News Conference News AHA 2021

Aspirin Fails to Prevent Onset of Dementia in Diabetic Patients: ASCEND

Michael O'Riordan

November 17, 2021

News Conference News AHA 2021

Canagliflozin Improves Quality of Life in HF Patients

Michael O'Riordan

November 16, 2021

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 3

Todd Neale

November 15, 2021

Advertisement

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Glancing Back, Looking Forward: Lasting Lessons for Years to Come

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

British Medical Groups Express Concern About Inclisiran Rollout

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

Another Study Links Stopping Statins to MACE in the Elderly

Penumbra’s JET 7 Recall: A Kick Start to Change?

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Aspirin Fails to Prevent Onset of Dementia in Diabetic Patients: ASCEND

Canagliflozin Improves Quality of Life in HF Patients

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

COVID-19: TCTMD’s Dispatch for November Week 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content